A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitor treatment to sirolimus treatment versus continued calcineurin inhibitor treatment in liver allograft recipients undergoing maintenance therapy

Trial Profile

A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitor treatment to sirolimus treatment versus continued calcineurin inhibitor treatment in liver allograft recipients undergoing maintenance therapy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Ciclosporin; Sirolimus; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Jan 2012 Results published in the American Journal of Transplantation.
    • 15 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top